Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MindWalk Holdings Corp. (HYFT : NSDQ)

• Company Description    MindWalk is a Bio-Native AI company transforming drug discovery and development. MindWalk, formerly known as ImmunoPrecise Antibodies Ltd., is based in AUSTIN, Texas. Number of Employees: 102

• Price / Volume Information    Yesterday's Closing Price: $1.45 Daily Weekly Monthly 20 Day Moving Average: 395,606 shares Shares Outstanding: 46.16 (millions) Market Capitalization: $66.93 (millions) Beta: 0.51 52 Week High: $3.25 52 Week Low: $0.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -28.57% -28.63% 12 Week -24.48% -25.23% Year To Date -20.33% -20.74%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3204-4464 Markham Street - Victoria,A1 V8Z 7X8 CAN ph: 250-483-0308 fax: - investors@immunoprecise.com http://www.immunoprecise.com

• General Corporate Information    Officers Jennifer Bath - Chief Executive Officer Joseph Scheffler - Chief Financial Officer Kari Graber - Vice President Shuji Sato - Vice President Ilse Roodink - Chief Scientific Officer Peer Information MindWalk Holdings Corp. (EVOL) MindWalk Holdings Corp. (RAMP) MindWalk Holdings Corp. (LGTY) MindWalk Holdings Corp. (ALOT) MindWalk Holdings Corp. (CXT) MindWalk Holdings Corp. (TGHI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Technology Services Sector: Business Services CUSIP: 602687105 SIC: 2834 Fiscal Year Fiscal Year End: April Last Reported Quarter: 10/01/25 Next Expected EPS Date: 03/27/26 Share - Related Items Shares Outstanding: 46.16 Most Recent Split Date: (:1) Beta: 0.51 Market Capitalization: $66.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.03 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.19 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/27/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.25 Price/Cash Flow: - Price / Sales: 4.62 EPS Growth vs. Year Ago Period: 28.57% vs. Previous Quarter: 28.57% Sales Growth vs. Year Ago Period: -33.73% vs. Previous Quarter: 30.11% ROE 01/31/26 - - 10/31/25 - -56.75 07/31/25 - -45.70 ROA 01/31/26 - - 10/31/25 - -31.55 07/31/25 - -24.48 Current Ratio 01/31/26 - - 10/31/25 - 4.19 07/31/25 - 2.17 Quick Ratio 01/31/26 - - 10/31/25 - 4.09 07/31/25 - 2.14 Operating Margin 01/31/26 - - 10/31/25 - -61.13 07/31/25 - -52.55 Net Margin 01/31/26 - - 10/31/25 - -145.58 07/31/25 - -129.12 Pre-Tax Margin 01/31/26 - - 10/31/25 - -166.92 07/31/25 - -150.77 Book Value 01/31/26 - - 10/31/25 - 0.28 07/31/25 - 0.33 Inventory Turnover 01/31/26 - - 10/31/25 - 6.66 07/31/25 - 5.90 Debt-to-Equity 01/31/26 - - 10/31/25 - 0.18 07/31/25 - 0.16 Debt-to-Capital 01/31/26 - - 10/31/25 - 15.33 07/31/25 - 13.76

Powered by Zacks Investment Research ©